Grant

A Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy

Sponsored by Mayo Foundation for Medical Education and Research (Mayo Clinic)

$104K Funding

1 People

External

Related Topics

nephropathy, immunosuppressive, rituximab, cyclosporine, randomized trial

People

Amy Sussman
Principal Investigator (PI)
Medicine﹒Professor